DUSSELDORF, Germany, March 31 (Reuters) - DHL

said on Monday it will acquire U.S. pharmaceutical logistics

firm Cryopdp as part of the German company's efforts to grow its

operations in the pharma sector, confirming an earlier report by

Reuters.

DHL did not disclose a purchase price for the deal, which

foresees the German logistics giant buying 100% of the specialty

courier. A source familiar with the matter told Reuters that DHL

would pay a three-digit million-euro sum.

The companies have also agreed to a strategic partnership to

strengthen their supply chain service offerings for the global

life sciences and healthcare sector, DHL said in a statement.

Cryopdp ships products for pharmaceutical and biotech

companies, as well as offering storage and packaging services.

DHL hopes the deal will strengthen its Life Sciences and

Healthcare segments, which generated over 5 billion euros

($5.41 billion) in revenue in 2024.

The deal and the outlined partnership are subject to

regulatory approvals, the company said.

($1 = 0.9247 euros)